Clinical Trials

29 enrolled

Liver Neoplasms

NCT07206589 2026-04-17

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

1,010 enrolled

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT07535632 2026-04-17

BEST

58 enrolled

Colorectal Neoplasms

NCT07535840 2026-04-17

A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma

25 enrolled

Carcinoma, Hepatocellular

NCT07536321 2026-04-17

Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.

46 enrolled

Rectal Neoplasms

NCT07536841 2026-04-17

ОС26

82 enrolled

Immunoglobulin G4-Related Disease, Autoimmune Pancreatitis, Pancreatic Neoplasms, Pancreatitis, Chronic

NCT07537777 2026-04-17

Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy

29 enrolled

Phase 3 Not yet recruiting

Carcinoma, Hepatocellular

NCT07537946 2026-04-17

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

400 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT07537959 2026-04-17

Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases

280 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT07537972 2026-04-17

Denosumab Strategy for Liver Cancer With Bone Metastases

50 enrolled

Carcinoma, Hepatocellular

NCT07532759 2026-04-16

Impact of Intraoperative PTCD Catheter Retention Versus Removal on Postoperative Short-term Outcomes After Pancreaticoduodenectomy in Obstructive Jaundice

100 enrolled

Biliary Tract Neoplasms, Jaundice, Obstructive

NCT07533357 2026-04-16

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

158 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07535125 2026-04-16

IPEX

600 enrolled

Exocrine Pancreatic Insufficiency

NCT05936931 2026-04-15

Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening

Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening

NCT07036978 2026-04-15

Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer

140 enrolled

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07360119 2026-04-15

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

Pancreatic Neoplasms

NCT07530549 2026-04-15

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

40 enrolled

Esophageal Neoplasms

NCT07225309 2026-04-14

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

BreastGastrointestinalGenitourinaryHead & Neck

300 enrolled

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07436637 2026-04-14

Guardant Shield Colorectal Cancer Screening

500 enrolled

Colorectal Neoplasms

NCT07513116 2026-04-14

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

20 enrolled

Intermittent Fasting, Pancreatic Neoplasms

NCT07527520 2026-04-14

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

165 enrolled

Rectal Neoplasms

NCT07528430 2026-04-14

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer

450 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT07529483 2026-04-14

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts

35 enrolled

Pancreatic Cystic Neoplasm

NCT07529626 2026-04-14

MIND-PANC

320 enrolled

Pancreatic cancer, adult, Anxiety Disorders, Depression, Pancreatic Neoplasms, Disease Progression

NCT07404228 2026-04-13

RESTAGE

115 enrolled

Rectal Neoplasms

NCT07494994 2026-04-13

SURGIMEDIA

60 enrolled

Pancreatic Neoplasms

NCT07521605 2026-04-13

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

44 enrolled

Rectal Cancer Patients

NCT07522177 2026-04-13

Animated Storytelling to Promote Colorectal Cancer Screening

3,000 enrolled

Phase 1/2 Not yet recruiting

Colorectal Cancer Screening

NCT07522411 2026-04-13

Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma

100 enrolled

Carcinoma, Hepatocellular

NCT07523035 2026-04-13

Colorectal Adenoma Cohort

1,280 enrolled

Colorectal Neoplasms

NCT07523152 2026-04-13

SAPPHIRE

GastrointestinalGynecologic

42 enrolled

Anal Canal Carcinoma, Anus Neoplasms, Pelvic Neoplasms, Uterine Neoplasms, Vaginal Neoplasms

NCT07128355 2026-04-09

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Phase EARLY_PHASE1 Not yet recruiting

15 enrolled

Colorectal Neoplasms

NCT07211230 2026-04-09

Collagenase Biobank Study

107 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT07518706 2026-04-09

Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin

60 enrolled

Carcinoma, Hepatocellular

NCT07519681 2026-04-09

Effects of Berberine on the Human Gut Microbiome

20 enrolled

Phase 3 Not yet recruiting

Colorectal Neoplasms

NCT07520578 2026-04-09

SUIVICOLO

2,000 enrolled

Colorectal Cancer Screening

NCT07516392 2026-04-08

PRE-PDAC

1,140 enrolled

Genetic Risk Score, Pancreatic Neoplasms, Genetic Predisposition to Disease

NCT07517211 2026-04-08

A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study

72 enrolled

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

NCT07518680 2026-04-08

A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery

Esophageal Neoplasms

NCT07514429 2026-04-07

RELEVANT-HCC

24 enrolled

Carcinoma, Hepatocellular

NCT07514455 2026-04-07

RECOMEND

20 enrolled

Carcinoma, Hepatocellular, Disease Progression

NCT07514533 2026-04-07

The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma

60 enrolled

Cholangiocarcinoma

NCT07515469 2026-04-07

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Carcinoma, Hepatocellular

NCT07515625 2026-04-07

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

46 enrolled

Stomach Neoplasms

NCT07515729 2026-04-07

Raising Awareness of Colorectal Screening in American Indian Communities

446 enrolled

Colorectal Neoplasms

NCT07515820 2026-04-07

SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study

12 enrolled

Colorectal Neoplasms

NCT07515950 2026-04-07

REVEAL-BTC

244 enrolled

Biliary Tract Neoplasms

NCT07515963 2026-04-07

FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

24 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT07516210 2026-04-07

ART-Hypo

GastrointestinalGenitourinaryGynecologic

264 enrolled

Uterine Cervical Neoplasms, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT07496528 2026-04-06

ACURE

240 enrolled